魚內視鏡檢查（FISH）探針市場規模、佔有率和成長分析：按探針類型、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球 FISH 探針市場價值為 10.5 億美元，預計到 2025 年將成長至 11.2 億美元，到 2033 年將成長至 19.5 億美元，在預測期（2026-2033 年）內複合年成長率為 7.1%。

受腫瘤和遺傳疾病領域對精準分子診斷需求的不斷成長的推動，全球FISH探針市場正在擴張。對可靠細胞遺傳學檢測日益成長的需求，也帶動了FISH探針的穩定需求，FISH探針在腫瘤分層和血液系統惡性腫瘤監測的診斷過程中發揮著至關重要的作用。隨著相關人員越來越重視染色體水平的分析結果以指導治療決策，標靶治療也日益普及，對用於識別相關基因組突變的客製化伴隨診斷的需求也日益成長。自動化影像分析和多重檢測技術的進步正在提高檢測的準確性和效率。此外，數位病理學和即時檢測（PoC）解決方案的出現，以及對多探針檢測組合的投資，正在拓展臨床檢查室的能力，進一步推動市場成長和收入潛力。

全球FISH探針市場成長要素

全球FISH探針市場正受到影像處理和螢光檢測技術進步的顯著推動，這些技術的進步顯著提高了FISH探針的靈敏度和特異性。隨著實驗室在準確識別染色體異常和分子標靶的能力不斷提高，對FISH探針的需求在腫瘤學、遺傳學和感染疾病診斷等多個應用領域日益成長。這些技術進步不僅減少了所需的檢測次數，也擴大了FISH探針的應用範圍，促使臨床和研究機構採用這些創新技術。此外，影像處理能力的提升簡化了與自動化掃描系統的工作流程整合，使FISH檢測成為滿足精準細胞遺傳學和分子檢測需求的更便捷、更可重複且更具吸引力的選擇。

全球FISH探針市場的限制因素

全球FISH探針市場面臨許多限制因素，主要源自於FISH檢測的設計、檢驗與結果解讀的技術挑戰。進行此類檢測的檢查室面臨著熟練人員短缺和嚴格的品管措施等挑戰，這些挑戰可能導致FISH檢測的開發和實施出現顯著延誤。對於缺乏足夠財力支持相關流程的小規模臨床檢查室和研究機構而言，這個問題尤其突出。此外，準確選擇探針和建立標準化檢測流程不僅增加了工作量，也提高了對投資新型FISH產品相關風險的認知，最終限制了檢測數量和檢測能力的擴張速度。

全球FISH探針市場趨勢

受多重分析能力和空間分析技術進步的推動，全球FISH探針市場呈現上升趨勢。研究人員和臨床醫生擴大利用FISH檢測來研究完整組織結構中的多個標靶，從而促進這些檢測方法在診斷和研究中的應用。這種成長在腫瘤學和神經科學領域尤其顯著，這些領域對能夠提供空間和遺傳資訊並闡明細胞間相互作用的檢測方法的需求日益成長。因此，這一趨勢正在推動先進探針和檢測組合的開發，深化檢測方法開發人員和病理檢查室之間的合作，並簡化空間組織數據的臨床應用，從而促進生物標記的發現和異質性腫瘤的表徵。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球FISH探針市場規模：依探針類型分類

• DNA探針
• RNA探針
• 多重探針
• 全染色體探針
• 位點特異性探針
• 著絲粒/α-foid探針

全球FISH探針市場規模：依技術分類

• Q-FISH
• FLOW-FISH
• RNA-FISH
• 多路魚

全球FISH探針市場規模：依應用領域分類

• 癌症診斷
• 遺傳疾病的診斷
• 產前診斷
• 感染疾病檢測
• 個人化醫療
• 出於研究目的
• 其他

全球FISH探針市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 學術研究機構
• 生技公司
• 臨床研究機構
• 其他

全球FISH探針市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Revvity, Inc.
• Merck KGaA
• Danaher Corporation
• QIAGEN NV
• Sysmex Corporation
• Bio-Techne Corporation
• PerkinElmer Holdings, Inc.
• Illumina, Inc.
• Siemens Healthineers AG
• Becton, Dickinson and Company
• NeoGenomics, Inc.
• Natera, Inc.
• Exact Sciences Corporation
• Genomic Health, Inc.
• Eurofins Scientific SE

結論與建議

Global Fish Probe Market size was valued at USD 1.05 Billion in 2024 and is poised to grow from USD 1.12 Billion in 2025 to USD 1.95 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global market for FISH probes is on the rise, driven by the increasing demand for precise molecular diagnostics in oncology and genetic disorders. This growing need for reliable cytogenetic assays fosters a steady demand for FISH probes, which play a vital role in diagnostic pathways for stratifying tumors and monitoring blood cancers. As healthcare stakeholders emphasize chromosome-level insights for informed therapeutic decisions, the adoption of targeted therapies boosts the necessity for companion diagnostics tailored to identify relevant genomic alterations. Innovations in automated imaging and multiplex assays enhance testing accuracy and efficiency. Furthermore, the emergence of digital pathology and point-of-care solutions, along with investments in multiplex probe panels, are expanding testing capabilities in clinical laboratories, fueling market growth and revenue potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fish Probe market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fish Probe Market Segments Analysis

Global fish probe market is segmented by probe type, technology, application, end user and region. Based on probe type, the market is segmented into DNA probes, RNA probes, multiplex probes, whole chromosome probes, locus-specific probes and centromeric/alphoid probes. Based on technology, the market is segmented into Q-FISH, FLOW-FISH, RNA-FISH and multiplex FISH. Based on application, the market is segmented into cancer diagnostics, genetic disease diagnosis, prenatal diagnostics, infectious disease detection, personalized medicine, research applications and others. Based on end user, the market is segmented into hospitals, diagnostic laboratories, academic & research institutes, biotechnology companies, clinical research organizations and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fish Probe Market

The Global Fish Probe market is significantly driven by advancements in imaging and fluorescence detection technologies, which enhance the sensitivity and specificity of FISH probes. As laboratories gain the ability to accurately identify chromosomal abnormalities and molecular targets, the demand for these probes increases across diverse applications, including oncology, genetics, and infectious disease diagnostics. These technical enhancements not only reduce the number of tests needed but also broaden the utilization of FISH probes, leading clinical and research institutions to embrace these innovations. Furthermore, improved imaging capabilities have streamlined workflow integration with automated scanning systems, making FISH assays more accessible, reproducible, and appealing for accurate cytogenetic and molecular testing needs.

Restraints in the Global Fish Probe Market

The Global Fish Probe market faces several constraints primarily due to the technical challenges associated with the design, validation, and interpretation of FISH assays. Laboratories aiming to conduct these assays encounter hurdles related to a shortage of skilled personnel and the necessity for stringent quality control measures, which can cause significant delays in developing and implementing FISH tests. This issue is particularly pronounced in smaller clinical laboratories and research institutions that lack the financial resources to adequately support these processes. Additionally, the need for precise probe selection and the establishment of standardized testing procedures not only heightens the operational burden but also amplifies perceived risks linked to investing in novel FISH products, ultimately restricting both the volume of tests conducted and the rate at which testing capabilities can be expanded.

Market Trends of the Global Fish Probe Market

The global fish probe market is witnessing an upward trend driven by advancements in multiplexing capabilities and spatial profiling techniques. Researchers and clinicians are increasingly utilizing FISH assays to explore multiple targets within intact tissue architecture, enhancing the contextual application of these assays in diagnostics and research. This growth is particularly prominent in oncology and neuroscience, where there's a rising demand for assays that elucidate cellular interactions while delivering spatial and genetic insights. Consequently, this trend is fostering the development of sophisticated probes and panels, fostering collaboration between assay developers and pathology laboratories to streamline the clinical application of spatial tissue data, thereby enhancing biomarker discovery and the characterization of heterogeneous tumors.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global FISH Probe Market Size by Probe Type & CAGR (2026-2033)

• Market Overview
• DNA Probes
• RNA Probes
• Multiplex Probes
• Whole Chromosome Probes
• Locus-Specific Probes
• Centromeric/Alphoid Probes

Global FISH Probe Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Q-FISH
• FLOW-FISH
• RNA-FISH
• Multiplex FISH

Global FISH Probe Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer Diagnostics
• Genetic Disease Diagnosis
• Prenatal Diagnostics
• Infectious Disease Detection
• Personalized Medicine
• Research Applications
• Others

Global FISH Probe Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Biotechnology Companies
• Clinical Research Organizations
• Others

Global FISH Probe Market Size & CAGR (2026-2033)

• North America (Probe Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Probe Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Probe Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Probe Type, Technology, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Probe Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomic Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations